Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds
- PMID: 19853296
- PMCID: PMC4367859
- DOI: 10.1016/j.biomaterials.2009.10.010
Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds
Abstract
Half mustard (CEES) and nitrogen mustard (NM) are commonly used surrogates and vesicant analogs of the chemical warfare agent sulfur mustard. In the current study, in situ forming poly(ethylene glycol) (PEG)-based doxycycline hydrogels are developed and evaluated for their wound healing efficacy in CEES and NM-exposed rabbit corneas in organ culture. The hydrogels, characterized by UV-Vis spectrophotometry, rheometry, and swelling kinetics, showed that the hydrogels are optically transparent, have good mechanical strength and a relatively low degree of swelling (<7%). In vitro doxycycline release from the hydrogel disks (0.25% w/v) was found to be biphasic with release half times of approximately 12 and 72h, respectively, with 80-100% released over a 7-day period. Permeation of doxycycline through vesicant wounded corneas was found to be 2.5 to 3.4 fold higher than non-wounded corneas. Histology and immunofluorescence studies showed a significant reduction of matrix metalloproteinase-9 (MMP-9) and improved healing of vesicant-exposed corneas by doxycycline hydrogels compared to a similar dose of doxycycline delivered in phosphate buffered saline (PBS, pH 7.4). In conclusion, the current studies demonstrate that the doxycycline-PEG hydrogels accelerate corneal wound healing after vesicant injury offering a therapeutic option for ocular mustard injuries.
Figures










Similar articles
-
Doxycycline hydrogels as a potential therapy for ocular vesicant injury.J Ocul Pharmacol Ther. 2010 Oct;26(5):407-19. doi: 10.1089/jop.2010.0099. J Ocul Pharmacol Ther. 2010. PMID: 20925577 Free PMC article.
-
Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries.Biomaterials. 2011 Feb;32(4):1204-17. doi: 10.1016/j.biomaterials.2010.08.117. Epub 2010 Oct 14. Biomaterials. 2011. PMID: 20950853 Free PMC article.
-
The beneficial effects of doxycycline, an inhibitor of matrix metalloproteinases, on sulfur mustard-induced ocular pathologies depend on the injury stage.Curr Eye Res. 2014 Aug;39(8):803-12. doi: 10.3109/02713683.2013.874443. Epub 2014 Feb 6. Curr Eye Res. 2014. PMID: 24502433
-
Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.Eur J Pharm Biopharm. 2014 Nov;88(3):575-85. doi: 10.1016/j.ejpb.2014.07.005. Epub 2014 Aug 1. Eur J Pharm Biopharm. 2014. PMID: 25092423 Review.
-
The Use of Hydrogel Dressings in Sulfur Mustard-Induced Skin and Ocular Wound Management.Biomedicines. 2023 Jun 2;11(6):1626. doi: 10.3390/biomedicines11061626. Biomedicines. 2023. PMID: 37371720 Free PMC article. Review.
Cited by
-
Doxycycline hydrogels as a potential therapy for ocular vesicant injury.J Ocul Pharmacol Ther. 2010 Oct;26(5):407-19. doi: 10.1089/jop.2010.0099. J Ocul Pharmacol Ther. 2010. PMID: 20925577 Free PMC article.
-
Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog.Toxicol Appl Pharmacol. 2013 Feb 1;266(3):439-42. doi: 10.1016/j.taap.2012.11.020. Epub 2012 Nov 30. Toxicol Appl Pharmacol. 2013. PMID: 23201461 Free PMC article.
-
Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.Pharm Res. 2012 Sep;29(9):2377-88. doi: 10.1007/s11095-012-0763-z. Epub 2012 May 9. Pharm Res. 2012. PMID: 22569800 Free PMC article.
-
Biodegradable poly(ethylene glycol) hydrogels based on a self-elimination degradation mechanism.Biomaterials. 2010 Sep;31(26):6675-84. doi: 10.1016/j.biomaterials.2010.05.021. Epub 2010 Jun 19. Biomaterials. 2010. PMID: 20561680 Free PMC article.
-
Significance of Crosslinking Approaches in the Development of Next Generation Hydrogels for Corneal Tissue Engineering.Pharmaceutics. 2021 Feb 28;13(3):319. doi: 10.3390/pharmaceutics13030319. Pharmaceutics. 2021. PMID: 33671011 Free PMC article. Review.
References
-
- Blanc PD. The legacy of war gas. Am J Med. 1999;106(6):689–690. - PubMed
-
- Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol. 2006;31(1):1–5. - PubMed
-
- Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med. 1992;21(3):303–308. - PubMed
-
- Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol. 2007;19(5):451–456. - PubMed
-
- Papirmeister B. In: Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Papirmeister B, Feister AJ, Robinson SI, Ford RD, editors. Boca Raton, Fl: CRC Press; 1991.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous